logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
18/04/2026
The White House: Discussed partnership opportunities with the CEO of Anthropic, as well as the challenges faced in scaling up the application of this technology.
Latest
14 m ago
Trump reiterated that he will stop directly paying insurance companies.
25 m ago
Trump boasts about falling oil prices.
40 m ago
Meta paid $15.6 billion to Broadcom last year.
41 m ago
American Airlines has expressed no intention to merge with United Airlines.
44 m ago
As of Friday's closing, Kailera Therapeutics soared 62.5% on its first day of trading, reaching a market value of $3 billion. The company, founded in 2024, is developing four GLP-1-based weight-loss drugs, including an GLP-1/GIP dual receptor agonist injection HRS9531 licensed from Chinese partner Hengrui Medicine. The prospectus shows that Bain Capital and Hengrui Medicine are both shareholders with more than 5% stake in Kailera.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.